75 related articles for article (PubMed ID: 2422298)
1. Effect of 5-azacytidine on the differentiation of human leukemia K-562 cells.
Sasaki R; Miura Y
Int J Cell Cloning; 1986 May; 4(3):192-202. PubMed ID: 2422298
[TBL] [Abstract][Full Text] [Related]
2. Effect of 5-azacytidine on differentiation and DNA methylation in human promyelocytic leukemia cells (HL-60).
Christman JK; Mendelsohn N; Herzog D; Schneiderman N
Cancer Res; 1983 Feb; 43(2):763-9. PubMed ID: 6184156
[TBL] [Abstract][Full Text] [Related]
3. Long term instability and molecular mechanism of 5-azacytidine-induced DNA hypomethylation in normal and neoplastic tissues in vivo.
Lu LJ; Randerath K
Mol Pharmacol; 1984 Nov; 26(3):594-603. PubMed ID: 6208475
[TBL] [Abstract][Full Text] [Related]
4. Altered queuine modification of transfer RNA involved in the differentiation of human K562 erythroleukemia cells in the presence of distinct differentiation inducers.
Chen YL; Wu RT
Cancer Res; 1994 Apr; 54(8):2192-8. PubMed ID: 7513611
[TBL] [Abstract][Full Text] [Related]
5. DNA modification, differentiation, and transformation.
Jones PA; Taylor SM; Wilson V
J Exp Zool; 1983 Nov; 228(2):287-95. PubMed ID: 6198436
[TBL] [Abstract][Full Text] [Related]
6. Methylation and expression of c-myc and c-abl oncogenes in human leukemic K562 cells before and after treatment with 5-azacytidine.
del Senno L; Barbieri R; Amelotti F; Bernardi F; Buzzoni D; Marchetti G; Patracchini P; Piva R; Rossi M; Conconi F
Cancer Detect Prev; 1986; 9(1-2):9-15. PubMed ID: 2425967
[TBL] [Abstract][Full Text] [Related]
7. Five azacytidine, a DNA methyltransferase inhibitor, specifically inhibits testicular cord formation and Sertoli cell differentiation in vitro.
Mizukami T; Kanai Y; Fujisawa M; Kanai-Azuma M; Kurohmaru M; Hayashi Y
Mol Reprod Dev; 2008 Jun; 75(6):1002-10. PubMed ID: 18033690
[TBL] [Abstract][Full Text] [Related]
8. Effects of retinoids on induction of differentiation of cultured mouse myeloid leukemia cells.
Takenaga K; Hozumi M; Sakagami Y
Cancer Res; 1980 Mar; 40(3):914-9. PubMed ID: 6937243
[TBL] [Abstract][Full Text] [Related]
9. Human leukemic K562 cells: differential effects of 5-azacytidine on DNA methylation of epsilon-, gamma-globin and 7SL RNA genes.
del Senno L; Conconi F; Barbieri R; Amelotti F; Bernardi F; Piva R; Viola L; Gambari R
Boll Soc Ital Biol Sper; 1984 Aug; 60(8):1613-9. PubMed ID: 6208920
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of hemoglobin accumulation by monoclonal antibodies to the human transferrin receptor is reversed by hemin.
Viola L; Biagini R; Barbieri R; Gambari R
Exp Hematol; 1987 Dec; 15(11):1145-52. PubMed ID: 2445597
[TBL] [Abstract][Full Text] [Related]
11. Enhancement by hemin of the sensitivity of K562 human leukemic cells to 1-beta-D-arabinofuranosylcytosine.
Okabe-Kado J; Hayashi M; Honma Y; Hozumi M
Cancer Res; 1986 Mar; 46(3):1239-43. PubMed ID: 3455882
[TBL] [Abstract][Full Text] [Related]
12. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis.
Ray S; Bullock G; Nuñez G; Tang C; Ibrado AM; Huang Y; Bhalla K
Cell Growth Differ; 1996 Dec; 7(12):1617-23. PubMed ID: 8959329
[TBL] [Abstract][Full Text] [Related]
13. Terminal differentiation of the human promyelocytic leukemia cell line, HL-60, in the absence of cell proliferation.
Ferrero D; Tarella C; Gallo E; Ruscetti FW; Breitman TR
Cancer Res; 1982 Nov; 42(11):4421-6. PubMed ID: 6957259
[TBL] [Abstract][Full Text] [Related]
14. Tributyrin: a prodrug of butyric acid for potential clinical application in differentiation therapy.
Chen ZX; Breitman TR
Cancer Res; 1994 Jul; 54(13):3494-9. PubMed ID: 8012972
[TBL] [Abstract][Full Text] [Related]
15. Effect of uridine on response of 5-azacytidine-resistant human leukemic cells to inhibitors of de novo pyrimidine synthesis.
Grant S; Bhalla K; Gleyzer M
Cancer Res; 1984 Dec; 44(12 Pt 1):5505-10. PubMed ID: 6208998
[TBL] [Abstract][Full Text] [Related]
16. Effect of 5-azacytidine treatment on mouse embryonal carcinoma cells.
Cremisi C
J Cell Physiol; 1983 Aug; 116(2):181-90. PubMed ID: 6190823
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation and globin gene expression in patients treated with 5-azacytidine.
Ley TJ; Anagnou NP; Noguchi CT; Schechter AN; DeSimone J; Heller P; Nienhuis AW
Prog Clin Biol Res; 1983; 134():457-74. PubMed ID: 6198660
[TBL] [Abstract][Full Text] [Related]
18. A monoclonal antibody to human transferrin receptor which inhibits erythroid differentiation of human leukemic K-562 cells.
Gambari R
Boll Soc Ital Biol Sper; 1984 Jun; 60(6):1283-5. PubMed ID: 6206881
[TBL] [Abstract][Full Text] [Related]
19. Induction of erythroid differentiation of K562 human leukemic cells by herbimycin A, an inhibitor of tyrosine kinase activity.
Honma Y; Okabe-Kado J; Hozumi M; Uehara Y; Mizuno S
Cancer Res; 1989 Jan; 49(2):331-4. PubMed ID: 2910452
[TBL] [Abstract][Full Text] [Related]
20. Mutant RAS selectively promotes sensitivity of myeloid leukemia cells to apoptosis by a protein kinase C-dependent process.
Gallagher AP; Burnett AK; Bowen DT; Darley RL
Cancer Res; 1998 May; 58(9):2029-35. PubMed ID: 9581849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
